| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $76.6M | -2.4% |
| SG&A Expense | $27.8M | -4.1% |
| Operating Income | -$104.3M | +2.1% |
| Income Tax | $0 | — |
| Net Income | -$96.0M | -11.7% |
| EPS (Basic) | -$4.83 | +52.2% |
| EPS (Diluted) | -$4.83 | +52.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.0M | -52.4% |
| Current Assets | $129.7M | -40.9% |
| Total Assets | $164.9M | -36.6% |
| Current Liabilities | $14.5M | -35.5% |
| Total Liabilities | $38.5M | -20.8% |
| Stockholders' Equity | $126.5M | -40.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.2M | +3.9% |
| Capital Expenditures | $1.5M | -49.8% |
| Investing Cash Flow | $9.7M | -83.6% |
| Financing Cash Flow | $3.1M | -95.8% |
| Free Cash Flow | -$95.7M | +5.2% |